Table 3 Clinical characteristics and outcomes: comparison of patients with and without asthma (n = 473)
Characteristic | Patients with asthma | Patients without asthma | P-Value* |
|---|---|---|---|
No. (%) (n = 137) | No. (%) (n = 336) | ||
Tachypnea | 60/137 (44) | 110/336 (33) | 0.07 |
Tachycardia | 88/137 (64) | 213/336 (63) | 0.86 |
Intensive care unit admission | 37/133 (28) | 108/321 (34) | 0.31 |
Mechanical ventilation | 16/127 (13) | 69/301 (23) | 0.02 |
Acute respiratory distress syndrome | 9/129 (7) | 38/292 (13) | 0.10 |
Sepsis syndrome | 7/128 (6) | 31/291 (11) | 0.12 |
Death | 5/137 (4) | 32/332 (10) | 0.04 |
Influenza antiviral agent receipt | |||
Any during hospitalization | 101/137 (74) | 270/336 (80) | 0.15 |
≤ 2 days of illness onset | 49/99 (50) | 106/269 (39) | 0.10 |
≤ 2 days of admission | 79/92 (86) | 219/253 (87) | 0.87 |
Median days from illness onset to antiviral initiation (range) | 3 (0 – 18) | 3 (0 – 32) | 0.06 |
Other treatment | |||
Antibiotics | 101/137 (74) | 260/336 (77) | 0.40 |
Steroids | 83/137 (61) | 96/336 (29) | <0.01 |